Alpha Tau Medical (DRTS) Depreciation and Depletion (2021 - 2022)

Alpha Tau Medical's (DRTS) quarterly Depreciation and Depletion came in at $244000.0 in Q2 2022, up 5.63% quarter-over-quarter from $231000.0 in Q1 2022.

Alpha Tau Medical (DRTS) Depreciation and Depletion (2021 - 2022) Analysis & Trends

Alpha Tau Medical has disclosed Depreciation and Depletion across 2 years of filings, most recently posting $244000.0 for Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 1,395.22
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -1,330.00
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn -
9 Abivax 95.45 Bn 95.45 Bn - -
10 Alpha Tau Medical 2,384.20 -76.42 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 244,000.00
Jun 30, 2022 244,000.00
Mar 31, 2022 231,000.00
Mar 31, 2022 231,000.00
Mar 31, 2021 164,000.00
Mar 31, 2021 164,000.00